Great Point Partners

Dr. Jeffrey Jay and David Kroin co-founded the firm in 2003 and serve as Senior Managing Directors overseeing all investment activity. Dr. Jay focuses on therapeutics and medical device investing, drawing on his background as a practicing physician and earlier venture capital experience. David Kroin manages the private equity portfolio operations and firm administration.

The firm combines a proprietary industry network built from two decades of sole-sector focus with relationships among hospital systems, physician groups, and life-science entrepreneurs. Its public-markets hedge fund platform also serves as an intelligence channel, identifying private-company investment opportunities before formal auction processes begin. The firm's medical advisory network includes practicing clinicians who provide referrals and technical diligence.

Both. Great Point runs a private equity strategy focused on control buyouts and growth recapitalizations in middle-market healthcare companies, alongside a separate public securities hedge fund that invests in equities and credit within the same sector boundaries. In 2023 the firm expanded its credit capability with a dedicated healthcare lending fund.

All investment activity is contained within the life sciences ecosystem. Primary subsectors include medical devices, healthcare services (including physician practice management, specialty pharmacy, and outsourced hospital services), biopharmaceuticals, and diagnostics. The firm has consummated consolidations in contract research organizations and niche pharmaceutical delivery platforms.

The private equity group targets growth-stage and mature middle-market companies, typically those with $5 million to $30 million in EBITDA. Deal structures include management buyouts, corporate divestitures, growth equity infusions, and distressed restructurings. The hedge fund platform covers companies from IPO-stage through large-cap publicly traded life-science firms.

The firm's capital base consists of institutional limited partners, including university endowments, foundations, pension funds, and family offices. There is no single-family wealth anchor; it operates as a traditional private investment manager raising committed fund vehicles from external investors.

Yes, Great Point has historically offered co-investment opportunities to limited partners in select private equity transactions where deal size exceeds the target position for the fund vehicle. The co-investment structure typically involves no management fee or a reduced carry, though specific terms remain private between the firm and participating LPs.